{
  "downs": 0,
  "mod_reports": [],
  "secure_media_embed": {},
  "_info_url": "https://api.reddit.com/api/info/",
  "gilded": 0,
  "num_comments": 9,
  "_orphaned": {},
  "hidden": false,
  "ups": 15,
  "url": "https://www.reddit.com/r/ADHD/comments/11wy7b/pfizer_in_deal_to_acquire_nextwave_developer_of_a/",
  "_has_fetched": true,
  "quarantine": false,
  "name": "t3_11wy7b",
  "author_flair_text": "ADHD-PI",
  "user_reports": [],
  "saved": false,
  "permalink": "https://www.reddit.com/r/ADHD/comments/11wy7b/pfizer_in_deal_to_acquire_nextwave_developer_of_a/?ref=search_posts",
  "over_18": false,
  "is_self": true,
  "_params": {},
  "thumbnail": "self",
  "created_utc": 1350956389.0,
  "_replaced_more": false,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p><a href=\"http://online.wsj.com/article/SB10001424052970203406404578072362237045962.html\">http://online.wsj.com/article/SB10001424052970203406404578072362237045962.html</a></p>\n\n<p>&quot;Pfizer Inc. on Monday said it plans to acquire the developer of a drug for attention-deficit/hyperactivity disorder in a deal potentially valued at up to $700 million.</p>\n\n<p>The deal gives Pfizer an entry into an ADHD treatment market in which Shire and Johnson &amp; Johnson have had success with branded drugs but also face competition from low-price generics. The deal is part of a strategy to expand Pfizer&#39;s established-products unit partly by selling new, branded formulations of older drugs.</p>\n\n<p>...</p>\n\n<p>Quillivant XR is the first once-daily, extended-release formulation of liquid methylphenidate, and is designed to help increase attention in patients with ADHD. Various forms of methylphenidate are found in other ADHD drugs such as Ritalin and Concerta. The liquid formulation is intended for patients who have difficulty swallowing pills or capsules.&quot; -Peter Loftus, WSJ 10/22/12</p>\n\n<p>Edit: <a href=\"http://www.mercurynews.com/business/ci_21831535/pfizer-will-buy-nextwave-pharma-up-700m\">Alternate article from Mercury News</a></p>\n\n<p>Edit 2: To be clear, <a href=\"http://www.forbes.com/sites/matthewherper/2012/10/22/the-molecule-in-ritalin-keeps-generating-revenue/\">Quillivant is simply Ritalin</a> repackaged in liquid form so that people that experience trouble taking pills have an alternative form of ingestion.  NextWave is also working on a chewable tablet version they hope to submit to the FDA for approval some time next year.</p>\n</div><!-- SC_ON -->",
  "author_flair_css_class": "PURPLE",
  "subreddit_id": "t5_2qnwb",
  "archived": true,
  "domain": "self.ADHD",
  "clicked": false,
  "score": 15,
  "id": "11wy7b",
  "stickied": false,
  "media_embed": {},
  "visited": false,
  "selftext": "http://online.wsj.com/article/SB10001424052970203406404578072362237045962.html\n\n\"Pfizer Inc. on Monday said it plans to acquire the developer of a drug for attention-deficit/hyperactivity disorder in a deal potentially valued at up to $700 million.\n\nThe deal gives Pfizer an entry into an ADHD treatment market in which Shire and Johnson & Johnson have had success with branded drugs but also face competition from low-price generics. The deal is part of a strategy to expand Pfizer's established-products unit partly by selling new, branded formulations of older drugs.\n\n...\n\nQuillivant XR is the first once-daily, extended-release formulation of liquid methylphenidate, and is designed to help increase attention in patients with ADHD. Various forms of methylphenidate are found in other ADHD drugs such as Ritalin and Concerta. The liquid formulation is intended for patients who have difficulty swallowing pills or capsules.\" -Peter Loftus, WSJ 10/22/12\n\nEdit: [Alternate article from Mercury News](http://www.mercurynews.com/business/ci_21831535/pfizer-will-buy-nextwave-pharma-up-700m)\n\nEdit 2: To be clear, [Quillivant is simply Ritalin](http://www.forbes.com/sites/matthewherper/2012/10/22/the-molecule-in-ritalin-keeps-generating-revenue/) repackaged in liquid form so that people that experience trouble taking pills have an alternative form of ingestion.  NextWave is also working on a chewable tablet version they hope to submit to the FDA for approval some time next year.",
  "hide_score": false,
  "_api_link": "https://api.reddit.com/r/ADHD/comments/11wy7b/pfizer_in_deal_to_acquire_nextwave_developer_of_a/?ref=search_posts",
  "locked": false,
  "edited": 1350965006.0,
  "title": "\"Pfizer in Deal to Acquire NextWave... developer of a new liquid ADHD drug called Quillivant XR\" which is expected to be available January 2013.",
  "created": 1350956389.0,
  "_comments_by_id": {}
}